ArticleJCI insight2019

CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis.

Li-Chung Tsao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.